Elauwit Connection
ELWT · NASDAQ
About ELWT
- Employees
- 33
- Headquarters
- Columbia, South Carolina
- Listed
- Nov 5, 2025
- Sector
- Communication Services
- Industry
- Diversified Telecommunication Services
- Website
- elauwit.com
ELWT key statistics
- Market cap
- 36.81M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 12.55K
- Volume
- 17.73K
- Open price
- $5.46
- High today
- $5.72
- Low today
- $5.26
- 52 Week high
- $9.72
- 52 Week low
- $4.11
Elauwit Connection (ELWT) at a glance
As of Oct 20, 2026, Elauwit Connection (ELWT) shares are priced at $5.56, giving the company a market cap of 36.81M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $5.26 and $5.72. The current price is 5.8% above the day's low and 2.7% below its high.
Volume so far is 17.73K shares, above the average of 12.55K shares a day.
Over the past year Elauwit Connection has ranged from $4.11 to $9.72, and now sits 26% of the way up that range.
Elauwit Connection met or beat analyst EPS estimates in 2 of the last 4 quarters. In Q2 FY26 it reported -$0.47 per share against an estimate of -$0.2448.
The average analyst price target is $10.20, 83.5% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy100.0%
- Hold0.0%
- Sell0.0%
- Low
- $10.10
- Now
- $5.56
- High
- $10.50
ELWT earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 2 of the last 4 quarters, by 100.0% on average.
- Q3 FY25: reported $0.01 per share against an estimate of -$0.0102
- Q4 FY25: reported -$0.03 per share against an estimate of -$0.0306
- Q1 FY26: reported -$0.33 per share against an estimate of -$0.2244
- Q2 FY26: reported -$0.47 per share against an estimate of -$0.2448
ELWT news
- Press releaseNewsfile
- Press releaseNewsfile
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
- Press releaseNewsfile
ROSEN, A LEADING LAW FIRM, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
- Press releaseNewsfile
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
- Press releasePRNewswire
Rosen Law Firm Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
- Press releaseNewsfile
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
- Press releaseNewsfile
ROSEN, REGARDED INVESTOR COUNSEL, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
- Press releaseNewsfile
ROSEN, A GLOBAL INVESTOR RIGHTS FIRM, Encourages Elauwit Connection, Inc. Investors to Inquire About Securities Class Action Investigation - ELWT
Similar companies
Companies in the same industry as Elauwit Connection
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.